Form 4: Tevogen Bio Holdings CFO Increases Stake with Recent Stock Purchase

Kirti Desai, CFO of Tevogen Bio Holdings Inc., recently purchased 3,000 shares of common stock at $0.82 per share, increasing his total holdings to 9,699,186 shares.

Summary

• On June 12, 2024, Kirti Desai, the Chief Financial Officer of Tevogen Bio Holdings Inc., acquired 3,000 shares of the company's common stock.
• The purchase price was $0.82 per share.
• Following this transaction, Desai directly owns 9,699,186 shares of Tevogen Bio Holdings Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase indicates confidence, but it's a relatively small transaction in the context of overall holdings.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The stock purchase by the CFO could positively influence shareholder sentiment.

Key Dates